Not logged in Share Save
Plain language summary of publication: Comparing nivolumab and neoadjuvant chemotherapy with placebo and neoadjuvant chemotherapy in participants with newly diagnosed estrogen receptor-positive breast cancer in the CheckMate 7FL clinical trial Loi, Sherene; Salgado, Roberto; Curigliano, Giuseppe; Ivan Romero Diaz, Roberto; Delaloge, Suzette; Rojas Garcia, Carlos Ignacio; Kok, Marleen; Saura, Cristina; Harbeck, Nadia; Mittendorf, Elizabeth A.; Yardley, Denise A.; Suarez Zaizar, Alberto; Caminos, Facundo Rufino; Ungureanu, Andrei; Reinoso-Toledo, Joaquin G.; Guarneri, Valentina; Egle, Daniel; Ades, Felipe; Pacius, Misena; Chhibber, Aparna; Chandra, Rajalakshmi; Nathani, Raheel; Spires, Thomas; Qun Wu, Jenny; Pusztai, Lajos; Mcarthur, Heather Share Save
Share Save
Share Save
Share Save
Share Save
Clinical factors influencing retreatment with anti-PD-(L)1 therapies after treatment in early-stage cancers: a modified Delphi consensus study Pusztai, Lajos; Sondak, Vernon K.; Cappuzzo, Federico; Chouaid, Christos; Elder, Chris; Hirasawa, Yosuke; Ishida, Masaru; Jones, Robert; Lee, Seung Hyeun; Mizuno, Ryuichi; Nagata, Masayoshi; Okonji, David; Parente, Phillip; Shah, Bhavesh; Sun, Alexander; Ferreira, Dominihemberg; Spiteri, Carmel; Lauer, Andrea; Kaliasethi, Amrit; Kao, Carol; Kothari, Smita; Mckendrick, Jan Share Save
Share Save
Share Save
Share Save
A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer Mukhtar, Rita A.; Gottipati, Soumya; Yau, Christina; Lopez-Tarruella, Sara; Earl, Helena; Hayward, Larry; Hiller, Louise; Osdoit, Marie; van der Noordaa, Marieke; de Croze, Diane; Hamy, Anne-Sophie; Lae, Marick; Reyal, Fabien; Sonke, Gabe S.; Steenbruggen, Tessa G.; van Seijen, Maartje; Wesseling, Jelle; Martin, Miguel; del Monte-Millan, Maria; Boughey, Judy C.; Goetz, Matthew P.; Hoskin, Tanya; Valero, Vicente; Edge, Stephen B.; Abraham, Jean E.; Bartlett, John M. S.; Caldas, Carlos; Dunn, Janet; Provenzano, Elena; Sammut, Stephen-John; Thomas, Jeremy S.; Graham, Ashley; Hall, Peter; Mackintosh, Lorna; Fan, Fang; Godwin, Andrew K.; Schwensen, Kelsey; Sharma, Priyanka; Demichele, Angela M.; Cole, Kimberly; Pusztai, Lajos; Kim, Mi-Ok; van 't Veer, Laura; Cameron, David; Esserman, Laura J.; Fraser Symmans, W. Share Save
Pathologic complete response (pCR) rates for patients with HRD/HER2L high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial Huppert, L. A.; Wolf, D.; Yau, C.; Brown-Swigart, L.; Hirst, G. L.; Isaacs, C.; Pusztai, L.; Pohlmann, P. R.; Demichele, A.; Shatsky, R.; Yee, D.; Thomas, A.; Nanda, R.; Perlmutter, J.; Heditsian, D.; Hylton, N.; Symmans, F.; van't Veer, L. J.; Esserman, L.; Rugo, H. S. Share Save
GABAA receptor π forms channels that stimulate ERK through a G-protein-dependent pathway Wang, Yueyue; Zhang, Yalan; Li, Wenxue; Salovska, Barbora; Zhang, Jianan; Li, Tongqing; Li, Hengyi; Liu, Yansheng; Kaczmarek, Leonard K.; Pusztai, Lajos; Klein, Daryl E. Share Save
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial Rediti, Mattia; Venet, David; Joaquin Garcia, Andrea; Maetens, Marion; Vincent, Delphine; Majjaj, Samira; El-Abed, Sarra; Di Cosimo, Serena; Ueno, Takayuki; Izquierdo, Miguel; Piccart, Martine; Pusztai, Lajos; Loi, Sherene; Salgado, Roberto; Viale, Giuseppe; Rothe, Francoise; Sotiriou, Christos Share Save
Share Save
Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer Campbell, Michael J.; Wolf, Denise M.; Yau, Christina; Brown-Swigart, Lamorna; Wulfkuhle, Julie; Gallagher, Isela R.; Zhu, Zelos; Bolen, Jennifer; Vandenberg, Scott; Hoyt, Clifford; Mori, Hidetoshi; Borowsky, Alexander; Sit, Laura; Perlmutter, Jane; Asare, Smita M.; Nanda, Rita; Liu, Minetta C.; Yee, Douglas; Demichele, Angela M.; Hylton, Nola M.; Pusztai, Lajos; Berry, Donald A.; Hirst, Gillian L.; Petricoin, Emanuel F.; van't Veer, Laura; Esserman, Laura Share Save
Share Save
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial Khoury, Katia; Meisel, Jane L.; Yau, Christina; Rugo, Hope S.; Nanda, Rita; Davidian, Marie; Tsiatis, Butch; Chien, A. Jo; Wallace, Anne M.; Arora, Mili; Rozenblit, Mariya; Hershman, Dawn L.; Zimmer, Alexandra; Clark, Amy S.; Beckwith, Heather; Elias, Anthony D.; Stringer-Reasor, Erica; Boughey, Judy C.; Nangia, Chaitali; Vaklavas, Christos; Omene, Coral; Albain, Kathy S.; Kalinsky, Kevin M.; Isaacs, Claudine; Tseng, Jennifer; Torres, Evanthia T. Roussos; Thomas, Brittani; Thomas, Alexandra; Sanford, Amy; Balassanian, Ronald; Ewing, Cheryl; Yeung, Kay; Sauder, Candice; Sanft, Tara; Pusztai, Lajos; Trivedi, Meghna S.; Outhaythip, Ashton; Li, Wen; Onishi, Natsuko; Asare, Adam L.; Beineke, Philip; Norwood, Peter; Brown-Swigart, Lamorna; Hirst, Gillian L.; Matthews, Jeffrey B.; Moore, Brian; Symmans, W. Fraser; Price, Elissa; Beedle, Carolyn; Perlmutter, Jane; Pohlmann, Paula; Shatsky, Rebecca A.; Demichele, Angela; Yee, Douglas; van't Veer, Laura J.; Hylton, Nola M.; Esserman, Laura J. Share Save
Phosphoenolpyruvate carboxykinase-2 (PCK2) is a therapeutic target in triple-negative breast cancer Gunasekharan, Vignesh; Lin, Hao-Kuen; Marczyk, Michal; Rios-Hoyo, Alejandro; Campos, Gerson Espinoza; Shan, Naing Lin; Ahmed, Mostafa; Umlauf, Sheila; Gareiss, Peter; Raaisa, Raaisa; Williams, Richard; Cardone, Rebecca; Siebel, Stephan; Kibbey, Richard; Surovtseva, Yulia V.; Pusztai, Lajos Share Save